Aduro Clean Technologies (ACT) Q3 2025 earnings summary

Executive summary

• Expanded engineering capacity and leadership to support 2025 strategic goals, including new VP appointments.

• Filed a new patent for a novel process design to enhance Hydrochemolytic Technology (HCT) implementation.

• Completed Basic Engineering Design for HCT Next Generation Process (NGP) pilot plant, targeting commissioning in Q3 2025.

• Signed MOU with NexGen Polymers for collaboration on a demonstration-scale HCT plant.

• Marked Nasdaq listing milestone and increased investor engagement through events and conferences.

Financial highlights

• Q3 2025 revenue was $63,399, down 39% from Q3 2024; nine-month revenue was $156,542, down 33% year-over-year.

• All revenue is non-recurring, earned from customer engagement program services.

• Loss from operations increased to $2,851,772 in Q3 2025 from $2,027,383 in Q3 2024, driven by growth, hiring, share-based compensation, and Nasdaq listing expenses.

• Property, plant, and equipment carrying cost rose to $4.2 million, reflecting investment in research equipment and labs.

• Cash position remained strong at $8.4 million as of February 28, 2025.

Outlook and guidance

• Focus remains on advancing growth strategy, scaling up technology, and executing strategic priorities through fiscal 2025 and beyond.

• NGP pilot plant commissioning targeted for Q3 2025, with ongoing commercial scale-up and customer engagement programs.